HomeNDC LookupRxCUI directory › RxCUI 1370763

Hydrocortisone butyrate 1 MG/ML Topical Lotion — RxCUI 1370763

RxNorm drug concept · Semantic clinical drug
RxCUI 1370763 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 7 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1370763
Official nameHydrocortisone butyrate 1 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ashydrocortisone butyrate 0.1 % Topical Lotion
FDA products mapped4
Package NDCs mapped7
Reported Medicaid activity (SDUD)2,800 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydrocortisone Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This is a corticosteroid enema used specifically for ulcerative colitis that affects the lower part of your colon — the rectum and the left side. Rather than treating the whole bod...
  • What exactly is this enema treating — is it the same as regular colitis medicine?
  • Many people notice symptoms like diarrhea and bleeding improving within 3 to 5 days. That said, the actual healing of the colon lining often takes longer to show up — sometimes wee...
  • How long do I need to use it before it starts working?
📖 Read our full Hydrocortisone Rectal guide →

🕸️ Concept Web — How Hydrocortisone butyrate 1 MG/ML Topical Lotion Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Hydrocortisone butyrate 1 MG/ML Topical Lotion RxCUI 1370763

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Hydrocortisone 5492
    • Hydrocortisone butyrate 103468
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Evesse 2742556
    • Locoid 52147
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Hydrocortisone Topical Lotion 377713
    • Hydrocortisone butyrate Topical Lotion 2645482
    • Hydrocortisone Topical Product 1164013
    • Hydrocortisone butyrate Topical Product 2662286
    • Hydrocortisone Topical Lotion [Evesse] 2742559
    • Hydrocortisone Topical Lotion [Locoid] 385399
    • Hydrocortisone butyrate Topical Lotion [Evesse] 2742560
    • Hydrocortisone butyrate Topical Lotion [Locoid] 2655986
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Hydrocortisone butyrate 1 MG/ML 1370762
    • Hydrocortisone butyrate 1 MG/ML Topical Lotion [Evesse] 2742561
    • Hydrocortisone butyrate 1 MG/ML Topical Lotion [Locoid] 1370765
    • Hydrocortisone butyrate 1 MG/ML [Evesse] 2742557
    • Hydrocortisone butyrate 1 MG/ML [Locoid] 1370764

Showing up to 8 concepts per family — 17 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Hydrocortisone butyrate 1 MG/ML SCDC · 1370762
  • Hydrocortisone Topical Lotion SCDF · 377713
  • Hydrocortisone butyrate Topical Lotion SCDFP · 2645482
  • Hydrocortisone Topical Product SCDG · 1164013
  • Hydrocortisone butyrate Topical Product SCDGP · 2662286

Brand-Name Concepts

  • Hydrocortisone butyrate 1 MG/ML Topical Lotion [Evesse] SBD · 2742561
  • Hydrocortisone butyrate 1 MG/ML Topical Lotion [Locoid] SBD · 1370765
  • Hydrocortisone butyrate 1 MG/ML [Evesse] SBDC · 2742557
  • Hydrocortisone butyrate 1 MG/ML [Locoid] SBDC · 1370764
  • Hydrocortisone Topical Lotion [Evesse] SBDF · 2742559
  • Hydrocortisone Topical Lotion [Locoid] SBDF · 385399
  • Hydrocortisone butyrate Topical Lotion [Evesse] SBDFP · 2742560
  • Hydrocortisone butyrate Topical Lotion [Locoid] SBDFP · 2655986
  • Evesse Topical Product SBDG · 2742558
  • Locoid Topical Product SBDG · 1179154

📦 FDA Products & Package NDCs

4 products · 7 package NDCs
7 package NDCs map to RxCUI 1370763 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68180-0951-01 1 BOTTLE in 1 CARTON (68180-951-01) / 59 mL in 1 BOTTLE Hydrocortisone Butyrate Lupin Pharmaceuticals, Inc. 2018-08-17
68180-0951-02 1 BOTTLE in 1 CARTON (68180-951-02) / 118 mL in 1 BOTTLE Hydrocortisone Butyrate Lupin Pharmaceuticals, Inc. 2018-08-17
72162-2630-02 1 BOTTLE in 1 CARTON (72162-2630-2) / 59 mL in 1 BOTTLE Hydrocortisone Butyrate Bryant Ranch Prepack 2026-04-23
72162-2630-04 1 BOTTLE in 1 CARTON (72162-2630-4) / 118 mL in 1 BOTTLE Hydrocortisone Butyrate Bryant Ranch Prepack 2026-04-23
83148-0012-02 1 BOTTLE in 1 CARTON (83148-012-02) / 59 mL in 1 BOTTLE Hydrocortisone Butyrate The J. Molner Company LLC 2023-11-06
83148-0012-04 1 BOTTLE in 1 CARTON (83148-012-04) / 118 mL in 1 BOTTLE Hydrocortisone Butyrate The J. Molner Company LLC 2023-11-06
87143-0420-04 118 mL in 1 BOTTLE (87143-420-04) Evesse Perfero Pharma, Inc. 2026-05-04
Observed labelers: Bryant Ranch Prepack (2) · Lupin Pharmaceuticals, Inc. (2) · The J. Molner Company LLC (2) · Perfero Pharma, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.7000
Range $0.7000–$0.7000 · middle 50% $0.7000–$0.7000 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.